Congress

Pile of receipts

Politics

Want to know how contentious drug pricing is in Washington? Check the receipts

By Nicholas Florko

vape manufacturers/juul

Health

Congress calls Juul, four other vape companies to testify about youth vaping

By Nicholas Florko

advertisement

Rep. Chris Collins January 2020

Biotech

Former Rep. Chris Collins sentenced to 26 months in prison in biotech insider trading scheme

By Damian Garde and Lev Facher

advertisement

Alex Brandon/AP

Politics

Airing frustrations with pharma, a Republican FTC commissioner just endorsed Medicare negotiation

des moines debate

Politics

Democrats zero in on high drug prices in Iowa debate

California drug prices

Pharmalot

California plans to sell its own generic drugs in hopes of lowering costs

By Ed Silverman

Chuck Grassley Feb. 2019

Politics

Trump should do more to bolster Senate drug pricing effort, Grassley says

advertisement

Pharmalot

Pharmalittle: Execs vow to place patients ahead of profits; conservatives like Republican drug pricing bill

By Ed Silverman

advertisement

Calendar illustration

First Opinion

Medicare policy on antirejection drugs imperils kidney transplants

By Matthew Cooper

American Action Network ad

Politics

Conservative group with pharma ties makes clear there are drug pricing reforms they can support

By Nicholas Florko

Road to nowhere

Politics

Washington took a decade to approve an obscure drug-pricing bill. That’s a bad omen for more ambitious reforms

By Nicholas Florko

Rising Drug Cost

Pharmalot

It’s ‘business as usual’ as many drug makers boost prices for the new year

By Ed Silverman

2019 to Watch Congressional Races

Politics

3 congressional races to watch in 2020

Senate Finance Committee hearing on drug prices

Politics

2019 was supposed to be the year Washington lowered drug prices. What happened?

By Lev Facher and Nicholas Florko

Suboxone script

First Opinion

Orphan Drug Act’s ‘nonprofitability’ loophole needs to be closed

By Diane Dorman

Politics

Top Republican blasts McConnell for derailing bipartisan drug pricing bill

By Nicholas Florko

Pelosi - Lower Drug Costs Now Act

First Opinion

Takeaways from a biotech CEO on the House’s passage of H.R. 3

By Paul Hastings

DC Report

First Opinion

Deadline looms to stop the Health Insurance Tax — but Congress has been there before

By Allyson Y. Schwartz

FDA Nominee Stephen Hahn

Politics

Senate confirms Stephen Hahn, oncologist and political newcomer, as FDA commissioner

By Nicholas Florko

H.R. 3 press conference Pelosi

Politics

House passes major drug-pricing bill, a Democratic salvo in a showdown far from over

Lab coat and stethoscope

First Opinion

Congress: Don’t eliminate funding for the diversity creating Health Career Opportunity Program

By LaShyra Nolen

HR 3 ad/Politico

Politics

It’s a bonanza: With drug pricing bill up for a vote, D.C. news outlets are drowning in advocacy ads

By Nicholas Florko

Pramila Jayapal

Politics

After a long fight, progressives secure small tweaks to Pelosi’s drug pricing package

By Nicholas Florko

Nancy Pelosi Dec. 6

Politics

Democrats’ drug pricing bill is a sneak peek at the party’s 2020 campaign message

Trump in the Villages

Politics

With new trade deal, Trump deals a blow to drug makers

By Nicholas Florko

Pelosi - October 2019

Politics

What’s real — and what’s illusion — in drug pricing legislation on Capitol Hill

By Nicholas Florko

HR 3

First Opinion

H.R. 3 is the wrong path to lower drug costs

By Mike Guerra

Rep. Greg Walden

Politics

House Republicans fuel Capitol Hill chaos with competing drug pricing bill

Sen. Elizabeth Warren

Pharmalot

Lawmakers ask HHS for greater oversight of patient assistance programs

By Ed Silverman